Notice of Results and Appointment of Joint Broker

RNS Number : 0480M

Circassia Pharmaceuticals Plc

12 September 2019

 

Circassia Pharmaceuticals plc

Notice of Interim Results and Appointment of Joint Broker

Circassia Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR) announces it will publish its interim results for the six months ended 30 June 2019 on Thursday 26 September 2019.  A presentation for analysts will take place at 9.30am on the day and a webcast of the presentation will be available on the Company's website.

Circassia also announces the appointment of finnCap Ltd as joint broker with immediate effect.

Contacts

Circassia

Steve Harris, Chief Executive Officer                                                     Tel: [phone]

Julien Cotta, Chief Financial Officer

Rob Budge, Corporate Communications

Peel Hunt (Nominated Adviser and Joint Broker)

James Steel / Dr Christopher Golden                                                     Tel: [phone]

finnCap (Joint Broker)

Geoff Nash / Alice Lane                                                                          Tel: [phone]

Numis Securities (Joint Broker)

James Black / Freddie Barnfield                                                             Tel: [phone]

FTI Consulting

Simon Conway / Ciara Martin                                                                 Tel: [phone]

About Circassia

Circassia is a world-class specialty pharmaceutical business focused on respiratory disease.  The Company sells its market-leading NIOX® asthma management products directly to specialists in the United States, United Kingdom, China and Germany, and in a wide range of other countries through its network of partners.  In the United States, Circassia has a commercial collaboration with AstraZeneca in which it has the commercial rights to chronic obstructive pulmonary disease (COPD) treatments Tudorza® and Duaklir®.  Circassia also has the US and Chinese commercial rights to the late-stage ventilator-compatible nitric oxide product AirNOvent.  For more information please visit www.circassia.com.

 

END

 

 

MSCEAANFFELNEAF